TY - JOUR T1 - Three-year spirometric evolution after lobectomy in lung cancer patients with or without COPD previous surgery JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2016.PA2816 VL - 48 IS - suppl 60 SP - PA2816 AU - Walther Ivan Giron Matute AU - Daniel López-Padilla AU - Roberto Larrosa-Barrero AU - Nuria Arenas Valls AU - Ricardo García-Luján Y1 - 2016/09/01 UR - http://erj.ersjournals.com/content/48/suppl_60/PA2816.abstract N2 - Objective: Determine lung cancer patients' post-lobectomy functional evolution, measured by FEV1, and group comparison based on obstruction's severity over a 3-year period.Methods: Observational study of consecutive lung cancer patients who underwent lobectomy from 2007 to 2013. FEV1 absolute figures and percentages were used to determine baseline functional evolution (one month before surgery), at year 1, 2 and 3 after the procedure. COPD severity was classified according to the GOLD initiative, and the one-way ANOVA test was used to compare anual functional evolution.Results: A total of 234 patients were included, 187 men (79.9%), mean age 64±9 years. Spirometric evolution is presented in Table 1.View this table:TABLE 1. Spirometric evolution according to the GOLD obstruction severity groupsConclusions: A significant decline of FEV1 could be found in no COPD or mild COPD patients 1 year after lobectomy, although the moderate COPD group presented a persistent decline over the 3 years of study. By year 3, FEV1 decline in the three groups did not present significant differences. ER -